Disrupting the System ll Recap
|
|
Fixing the cancer clinical trial conundrum. Together.
|
|
“We always have to disrupt the system when the system does not serve the greater good.”
-- Congressman Bobby Rush, Lazarex Disruptor Award recipient
|
|
Thank you for attending our 2nd annual Disrupting the System roundtable on June 18th. We want to keep you engaged so that our discussions and ideas become more than that - they become actions that change the system, and cancer treatment outcomes, for the better for all cancer patients.
This communication connects you to our Disrupting the System II summary, a video and a photo album of the event. From time to time we will send you an update on outcomes associated with our panel discussions. You can help keep the energy up and the topics active by sharing your takeaways and highlights from the panels with your colleagues.
|
|
Left to right: Moderator: Laura Evans, President, Laura Evans Media, Glenn Ellis, Sr., MPH, President, Strategies for Well-Being, Jude Ngang, Manager, Clinical Research Study, Amgen, Dana Dornsife, Founder, Lazarex Cancer Foundation, Christian Downs, Executive Director, Assn of Community Cancer Centers
|
|
Lazarex Cancer Foundation hosted a panel of thought leaders at the National Press Club in Washington, D.C. to explore new ideas, science and breakthrough programs to fix the dysfunctional system. Some of the biggest disruptors and innovators in the fields of oncology, patient advocacy and public policy discussed ways to make advancements in cancer research more accessible to ALL patients.
The event was a lively and educational forum promoting cutting-edge developments intended to increase participation, minority enrollment and retention in cancer clinical trials. Discussions focused on engaging patients and improving access and equity while serving ALL patients AND spurring innovation.
|
|
Disrupting the System II Video
|
June 18, 2019 we hosted some of the biggest disruptors and innovators in oncology, patient advocacy and public policy to discuss making cancer research more accessible to ALL patients. Watch the video from this very important meeting.
|
|
|
Congressman Bobby Rush,
Lazarex Disruptor Award recipient
|
|
Disrupting the System II Photos
|
|
Left to right: Emanuel “Chip” Petricoin, Co-Founder and
Chief Science Officer, Perthera, Dana Dornsife,
Founder, Lazarex Cancer Foundation,
John Whyte, MD, MPH, Chief Medical Officer, WebMD
|
|
Jackie Hinckley, breast cancer survivor and Lazarex Cancer Foundation client, provided the patient perspective for this event.
|
|
About Lazarex Cancer Foundation
|
|
We improve the outcome of cancer care, giving hope, dignity and life to advanced stage cancer patients and the medically underserved by providing assistance with costs for FDA clinical trial participation, navigation through clinical trial options, community outreach and engagement. To learn more, please contact us at 925.820.4517, toll-free at 877.866.9523, or visit us at
www.lazarex.org.
|
|
 |
Please help us spread the word by sending this to a friend (or many!) who you think would be interested in Lazarex Cancer Foundation or one of our many events. Thanks!
|
|
|
|
Lazarex Cancer Foundation, P.O. Box 741, 50 Oak Court, Suite 200, Danville, CA 94526
|
|
|
|
|
|
|
